74 related articles for article (PubMed ID: 12457358)
1. The role of matrix metalloproteinases in rheumatoid tendon disease.
Jain A; Brennan F; Troeberg L; Nanchahal J
J Hand Surg Am; 2002 Nov; 27(6):1059-64. PubMed ID: 12457358
[TBL] [Abstract][Full Text] [Related]
2. Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
Jain A; Nanchahal J; Troeberg L; Green P; Brennan F
Arthritis Rheum; 2001 Aug; 44(8):1754-60. PubMed ID: 11508425
[TBL] [Abstract][Full Text] [Related]
3. Invasive potential of human rheumatoid tenosynovial cells is in part MT1-MMP dependent.
Jain A; Miller MC; Troeberg L; Itoh Y; Brennan F; Nanchahal J
J Hand Surg Am; 2009 Sep; 34(7):1282-90. PubMed ID: 19596176
[TBL] [Abstract][Full Text] [Related]
4. Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis.
Sivakumar B; Akhavani MA; Winlove CP; Taylor PC; Paleolog EM; Kang N
J Hand Surg Am; 2008 Jan; 33(1):49-58. PubMed ID: 18261665
[TBL] [Abstract][Full Text] [Related]
5. Comparative histopathological analysis between tenosynovitis and joint synovitis in rheumatoid arthritis.
Kaibara N; Yamada H; Shuto T; Nakashima Y; Okazaki K; Miyahara H; Esaki Y; Hirata G; Iwamoto Y
Histopathology; 2008 Jun; 52(7):856-64. PubMed ID: 18462359
[TBL] [Abstract][Full Text] [Related]
6. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
[TBL] [Abstract][Full Text] [Related]
9. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
10. Tendon cells produce gelatinases in response to type I collagen attachment.
Ritty TM; Herzog J
J Orthop Res; 2003 May; 21(3):442-50. PubMed ID: 12706016
[TBL] [Abstract][Full Text] [Related]
11. Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis.
Liu M; Sun H; Wang X; Koike T; Mishima H; Ikeda K; Watanabe T; Ochiai N; Fan J
Arthritis Rheum; 2004 Oct; 50(10):3112-7. PubMed ID: 15476203
[TBL] [Abstract][Full Text] [Related]
12. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.
O'Hara R; Murphy EP; Whitehead AS; FitzGerald O; Bresnihan B
Arthritis Rheum; 2004 Jun; 50(6):1788-99. PubMed ID: 15188355
[TBL] [Abstract][Full Text] [Related]
13. Type IV collagen alpha-chain composition in synovial lining from trauma patients and patients with rheumatoid arthritis.
Poduval P; Sillat T; Beklen A; Kouri VP; Virtanen I; Konttinen YT
Arthritis Rheum; 2007 Dec; 56(12):3959-67. PubMed ID: 18050191
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.
Bradley K; Scatizzi JC; Fiore S; Shamiyeh E; Koch AE; Firestein GS; Gorges LL; Kuntsman K; Pope RM; Moore TL; Han J; Perlman H
Arthritis Rheum; 2004 Jan; 50(1):78-87. PubMed ID: 14730602
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints.
Okada Y; Nagase H; Harris ED
J Rheumatol; 1987 May; 14 Spec No():41-2. PubMed ID: 3305938
[TBL] [Abstract][Full Text] [Related]
17. Flexor tendon ruptures in rheumatoid arthritis.
Ertel AN
Hand Clin; 1989 May; 5(2):177-90. PubMed ID: 2661574
[TBL] [Abstract][Full Text] [Related]
18. Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages.
Kim H; Kim WJ; Jeon ST; Koh EM; Cha HS; Ahn KS; Lee WH
Clin Immunol; 2005 Sep; 116(3):217-24. PubMed ID: 15993649
[TBL] [Abstract][Full Text] [Related]
19. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
Chang YH; Lin IL; Tsay GJ; Yang SC; Yang TP; Ho KT; Hsu TC; Shiau MY
Clin Biochem; 2008 Aug; 41(12):955-9. PubMed ID: 18471998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
